CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $264,622 | -19.1% | 14,227 | -44.2% | 0.08% | -42.1% |
| Q3 2022 | $327,000 | +48.0% | 25,480 | -19.3% | 0.13% | +15.7% |
| Q2 2022 | $221,000 | -37.0% | 31,571 | -25.4% | 0.12% | -1.7% |
| Q1 2022 | $351,000 | -4.9% | 42,293 | -22.6% | 0.12% | +34.5% |
| Q4 2021 | $369,000 | +27.7% | 54,618 | 0.0% | 0.09% | +26.1% |
| Q3 2021 | $289,000 | -8.0% | 54,618 | 0.0% | 0.07% | +97.1% |
| Q2 2021 | $314,000 | – | 54,618 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |